% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • slumdawg2011 slumdawg2011 Sep 27, 2013 4:15 PM Flag

    Roche’s Kadcyla Beats Herceptin in Delaying Cancer Progression

    ... in Bloomberg.

    "those receiving Kadcyla lived a median of 6.2 months without their disease progressing, compared with 3.3 months for those whose doctors chose a different therapy", including Herceptin + Tykerb

17.86-0.24(-1.33%)Jul 29 4:00 PMEDT